| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rein Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | 23 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNTX | Rein Therapeutics, Inc. | 23 Jul 2025 | 1 | $0 | 4 | 23 Jul 2025 | Director |
| ALRN | Aileron Therapeutics, Inc. | 02 Dec 2024 | 1 | $0 | 4 | 06 Dec 2024 | Director |
| ALRN | Aileron Therapeutics, Inc. | 20 Aug 2024 | 1 | $0 | 4 | 22 Aug 2024 | Director |
| ALRN | AILERON THERAPEUTICS INC | 30 Mar 2022 | 1 | $0 | 4/A | 30 Mar 2022 | President and Chief Executive Officer, Director |
| ALRN | AILERON THERAPEUTICS INC | 22 Mar 2022 | 1 | $0 | 4 | 24 Mar 2022 | President and Chief Executive Officer, Director |
| ALRN | AILERON THERAPEUTICS INC | 15 Jun 2021 | 1 | $0 | 4 | 17 Jun 2021 | President and Chief Executive Officer, Director |